We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Opdivo
Australian Public Assessment Report
Device/Product Name
Opdivo
Active ingredients
Nivolumab
AusPAR Date
Published
Submission Number
PM-2021-02518-1-4
Submission Type
Extension of indication
Decision
Approved